Response to: 'The utility of the HEp-2000 antinuclear antibody substrate' by Lee et al

Affiliations

¹ Maastricht University Medical Center, Maastricht, The Netherlands jan.damoiseaux@mumc.nl.
² Department of Oral Biology, University of Florida, Gainesville, Florida, United States.

Comment

Jan Damoiseaux et al. Ann Rheum Dis. 2020 Jun.

. 2020 Jun;79(6):e68.

doi: 10.1136/annrheumdis-2019-215610. Epub 2019 May 14.

¹ Maastricht University Medical Center, Maastricht, The Netherlands jan.damoiseaux@mumc.nl.
² Department of Oral Biology, University of Florida, Gainesville, Florida, United States.

No abstract available

Keywords: disease activity; inflammation; treatment.

Conflict of interest statement

Competing interests: None declared.

Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective.
Damoiseaux J, Andrade LEC, Carballo OG, Conrad K, Francescantonio PLC, Fritzler MJ, Garcia de la Torre I, Herold M, Klotz W, Cruvinel WM, Mimori T, von Muhlen C, Satoh M, Chan EK. Damoiseaux J, et al. Ann Rheum Dis. 2019 Jul;78(7):879-889. doi: 10.1136/annrheumdis-2018-214436. Epub 2019 Mar 12. Ann Rheum Dis. 2019. PMID: 30862649 Free PMC article.
Utility of the HEp-2000 antinuclear antibody substrate.
Lee AYS, Beroukas D, Roberts-Thomson PJ. Lee AYS, et al. Ann Rheum Dis. 2020 Jun;79(6):e67. doi: 10.1136/annrheumdis-2019-215519. Epub 2019 May 14. Ann Rheum Dis. 2020. PMID: 31088792 No abstract available.